Divine Blessings in Silver: MMTC-PAMP Launches 99.99%+ Silver Char Dham 20gm Coin Series Honouring India's Spiritual Compass
The colourful coins weigh 20 grams each and are made from 99.99%+ purest silver, making them ideal for collectors, gifting and spiritually inclined customers
Honouring the cultural and spiritual significance of the Char Dham Yatra, MMTC- PAMP, Indias only LBMA accredited Good Delivery Gold & Silver refiner and recognised as the purest precious metal brand in Asia and India, has launched a set of four (20 gram each) purest silver coins paying homage to Indias most revered pilgrimage destinations – Badrinath, Dwarka, Puri, and Rameswaram.
MMTC-PAMP Launches 99.99%+ Silver Char Dham 20gm Coin Series
Each 20-gram coin in this exclusive set is crafted from 99.99%+ purest silver, ensuring the highest purity standards while celebrating the architectural grandeur and spiritual significance of these four sacred sites. Additionally, each coin captures the unique mythological significance and distinct architectural essence of the respective pilgrimage site, making this collection a comprehensive tribute to Indias spiritual geography.
Speaking about the launch of the Char Dham collection, Mr Samit Guha, Interim CEO and CFTO of MMTC- PAMP, said, 'Our Char Dham collection is a uniquely crafted tribute to the four holiest pilgrimage sites of India, spread across four corners – Badrinath in the north, Dwarka in the west, Puri in the east, and Rameswaram in the south. Each of the four coins in this set celebrates one of the Char Dhams, capturing the spiritual, cultural significance, architectural marvel, and the beautiful landscape. Each piece in this collection tells a centuries-old story of devotion, connecting contemporary collectors with Indias timeless spiritual heritage through the finest Swiss craftsmanship.'
Embodying centuries of devotion and mythology, the colour-embossed Char Dham collection is more than just precious metals. These coins represent the spiritual journey, or yugas, of India, encompassing the Char Dham across the country, as espoused by the 8th-century Vedic scholar and philosopher Shri Adi Shankaracharya.
MMTC-PAMP's Char Dham Collection offers an exceptional value proposition for collectors who appreciate quality craftsmanship and purity. This collection is ideal for spiritual customers looking to celebrate the auspiciousness of these pilgrimage sites for religious occasions, festivals, and ceremonial celebrations. Furthermore, investors benefit from a precious metal investment that combines cultural and historical significance with Swiss-quality manufacturing, ensuring premium collectable status and potential appreciation due to limited availability and deep thematic relevance.
The Char Dham pilgrimage is considered a spiritual journey, cleansing the soul and deepening connection with the divine. The Char Dham collection by MMTC-PAMP is a tribute to this sentiment offering the purest silver with a commitment to showcase India's deep rooted cultural, civilizational values and celebrating the test of endurance and faith through these coins.
Every product created by MMTC-PAMP goes through a rigorous purification process to ensure 999.9+ (99.99%+) the purity of the metal. To validate the authenticity, every MMTC-PAMP product carries a unique number and comes packaged in Assayer Certified Minted Cards. Each gold and silver product bought from MMTC-PAMP offers positive weight tolerance, which guarantees that every coin or bar one buys weighs more than the listed weight, ensuring customers receive the highest value for their investment. MMTC-PAMP products are available at their exclusive stores, leading jeweller partners, online marketplaces such as Amazon and Flipkart, or directly from MMTC-PAMP's own website, www.mmtcpamp.com/shop.
About MMTC-PAMP
A joint venture between Switzerland-based bullion refinery, PAMP SA, and MMTC Ltd., a Miniratna and Government of India Undertaking. MMTC-PAMP is the only LBMA-accredited gold & silver good delivery refiner in India and is accepted across global commodity exchanges and central banks. The company seamlessly marries Swiss excellence with Indian insights. MMTC-PAMP India Pvt. Ltd. is internationally recognized as an industry leader in bringing global standards of excellence to the Indian precious metals industry.
MMTC-PAMP has received several awards since its inception from local and global industry bodies for Refining, Brand and Sustainability. Notably, MMTC-PAMP is Indias First Precious Metals Company to have Science-based Emissions Reduction Targets Approved by SBTI. Recognized by the Asia and India Book of Records, MMTC-PAMP is acclaimed as the country's only brand providing the purest gold and silver coins and bars with 99.99%+ purity levels and positive weight tolerance to consumers. Adding to its laurels, MMTC-PAMP was honoured as India's Most Trusted Brand of the Nation at The Brand Story- Indian Brand and Leadership Conclave & Awards, 2024.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
2 hours ago
- Hindustan Times
Religious conversion racket: ED unearths offshore trail of Panama shell firms for money laundering
Probing the alleged money-laundering activities of Jalaluddin Shah alias Chhangur Baba, 78, accused of being the kingpin of the Balrampur religious conversion racket, the Enforcement Directorate (ED) has discovered an offshore trail involving Panama-based shell companies, senior officials said. Jalaluddin Shah alias Chhangur Baba. (File Photo) 'While scanning the list of properties and investments, the ED has unearthed a complex offshore trail involving Panama-based shell companies suspected to have been used for laundering illicit wealth and concealing real ownership. Documents seized during a search operation revealed that Chhangur Baba's close associate, Naveen Rohra alias Jamaluddin, had registered companies in Panama, including Krishna Group SA and Logos Marine SA. These entities are suspected to have been used for money laundering and tax evasion,' a senior ED official confirmed. He said the ED is further investigating the source of funds used in these transactions and the nature of the companies' operations. The agency is also looking into potential international connections and the involvement of other individuals in the alleged money-laundering scheme, he added. The investigation revealed a general power of attorney issued in favour of Naveen Rohra, granting him operational authority over the companies, he said, adding that the probe also uncovered significant financial transactions between the companies and various entities, including those based in South Africa and the United Arab Emirates (UAE). The official said the ED has found evidence of property purchases made by Naveen Rohra and his associates, including his wife Neetu Rohra, using funds allegedly generated through illicit means. The agency has also traced a connection to Habib Bank in Zurich, Switzerland, raising suspicions about possible Swiss bank involvement in the funding and financial transactions related to the case, he said. Documents seized during the investigation also revealed a UAE entry permit linked to Chhangur Baba, indicating potential international connections, he added. The Uttar Pradesh Anti-Terrorism Squad (ATS) had registered an FIR against Chhangur Baba and his associates on November 16, 2024, accusing them of forced religious conversions and illegally amassing wealth. So far, eight people have been arrested, including Rajesh Kumar Upadhyaya, a clerk in the Balrampur Chief Judicial Magistrate (CJM) court, on July 19 for alleged connivance with the kingpin in the religious conversion racket.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
AstraZeneca unveils $50 bn US investment as pharma tariff threat looms
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy. The investment will fund a new drug manufacturing facility in Virginia and expand research and development (R&D) and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, it said in a statement. It will also upgrade the Anglo-Swedish drugmaker's U.S. clinical trial supply network and support ongoing investment in novel medicines. On Monday, AstraZeneca said the expansion supports its ambition to reach $80 billion in annual revenue by 2030, with half coming from the U.S. The U.S. accounted for more than 40% of AstraZeneca's annual revenue in 2024, and the company had been prioritising the market - the world's largest, worth $635 billion - before Trump's return to office. The move to scale up its U.S. footprint is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry and seeks to boost domestic manufacturing. The sector has historically been spared from trade disputes. Trump has called on pharma companies to make more of the medicines they sell in the U.S. within the country, rather than importing active ingredients or finished medicines. He is also pushing for prices in the U.S. to fall to what other countries pay. CEO Pascal Soriot announced the plans in Washington, saying he believes that drug prices need to rise elsewhere and "equalize" with other countries effectively contributing more to research and development costs. "The United States cannot build or carry the cost of R&D for the entire world," he said. U.S. Commerce Secretary Howard Lutnick's department is leading a probe into pharmaceutical imports that could pave the way for new tariffs. "For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness," said Lutnick in a statement issued by AstraZeneca. While Trump has repeatedly threatened tariffs on the sector, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any levies take effect. The company said that the timing and location of the announcement was linked to the U.S. policy environment, though some of the spending would have occurred regardless so that the infrastructure for future medicines was in place. The pledge is in addition to the $3.5 billion in investments the company announced in November 2024, the statement said. PLEDGES The $50 billion pledge matches the commitment announced by Swiss rival Roche in April and follows new spending plans unveiled this year by Eli Lilly & Co, Johnson & Johnson , Novartis, and Sanofi. Also present at the announcement was Virginia State Governor Glenn Youngkin, a vocal Trump ally who has defended the administration's tariff policies. The new Virginia facility - the company's largest single manufacturing investment - will produce active ingredients for AstraZeneca's experimental weight-loss medicines, including its oral GLP-1 candidate and an oral PCSK9 inhibitor for cholesterol management, it said. The company said the investment could create tens of thousands of new jobs, but declined to give specifics. It employs about 18,000 people in the U.S. and has a global workforce of about 90,000. In January it scrapped plans to invest 450 million pounds ($607.1 million) in its vaccine manufacturing plant in northern England, citing a cut in government support. Earlier this month, The Times reported the company was considering moving its stock market listing from London, where it is the exchange's most valuable company worth 159 billion pounds, to the U.S. The company declined to comment.
Time of India
3 hours ago
- Time of India
WEF spat heats up as founder Klaus Schwab denies misconduct
"I am in a position to refute all the accusations brought up against me," Schwab said in a statement, responding to a report in SonntagsZeitung. The Swiss newspaper said preliminary findings by Swiss law firm Homburger support allegations that Schwab manipulated economic reports published by the forum and submitted unjustifiably high expense claims. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads ZURICH: World Economic Forum founder Klaus Schwab denied allegations of misconduct that were reportedly substantiated by a formal investigation and accused the board of trustees of violating an agreement regarding media discretion on the matter."I am in a position to refute all the accusations brought up against me," Schwab said in a statement, responding to a report in SonntagsZeitung. The Swiss newspaper said preliminary findings by Swiss law firm Homburger support allegations that Schwab manipulated economic reports published by the forum and submitted unjustifiably high expense investigation, commissioned by the WEF's board of trustees, is examining a range of accusations against the 87-year-old, including claims he used the forum's resources for personal abruptly resigned from the WEF in April after the misconduct allegations emerged, sparking a clash with the board. A successor has yet to be figures linked to the role have included BlackRock Vice Chairman and former Swiss National Bank President Philipp Hildebrand , who joined the board of trustees in May, and European Central Bank President Christine Lagarde , who until recently was considered the top candidate by both Schwab and the organization, Bloomberg previously has said she first intends to complete her ECB term, which runs until October WEF board of directors is currently led by former Nestle Chairman Peter Brabeck-Letmathe on an interim his statement Sunday, Schwab said he made himself available for an interview with Homburger on July 15. He was told he would have access to a draft of the report to respond to the allegations. He has yet to see a draft, a spokesperson added in a separate statement."In this respect I feel deceived," Schwab said. "I am willing to defend my interests with all my strength, even in the context of a legal dispute."A WEF spokesperson declined to comment when contacted by Bloomberg, stating that the organization would respond once the investigation concludes, likely at the end of SonntagsZeitung report intensifies an ongoing dispute between Schwab and the board of trustees at WEF and comes just weeks after the two parties issued a joint statement claiming they were working toward "normalizing" their relationship and resolving the to excerpts cited by the newspaper, Homburger's investigation found that Schwab repeatedly intervened to influence country rankings in the WEF's Global Competitiveness Report for political investigation also scrutinized some 900,000 Swiss francs ($1.12 million) in expenses submitted by Schwab and his wife Hilde that allegedly lacked sufficient ties to WEF activities, the newspaper said.
